Healthcare DIVE January 26, 2026
Rebecca Pifer Parduhn

The company’s massive pharmacy benefit manager changed its rules and weaponized audits to ensure independent pharmacies couldn’t work with competing pharmacy service companies, House Republicans said.

Dive Brief

  • CVS may have violated federal antitrust laws by preventing independent pharmacies from working with rival pharmacy service companies that it viewed as a competitive threat, according to a new report from the House Judiciary Committee.
  • In late 2024, House Republicans opened an investigation into CVS’ relationships with pharmacy hubs, third-party companies that provide a range of digital pharmacy services to increase price transparency and patient access to drugs.
  • According to thousands of internal documents CVS provided to the committee, CVS changed its network rules and weaponized audits and cease-and-desist letters to...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

Continue Reading

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
Related Articles:
Q&A: New PQA Resource Highlights 40 Projects Targeting Social Determinants of Health
The Future of Pharmacovigilance Technology: How AI and Automation Are Redefining Drug Safety
Mirum Pharmaceuticals Completes $268.6 Million Acquisition of Bluejay Therapeutics to Strengthen Rare Disease Pipeline
The case for transparent pricing: Making pharmacy benefits work for health plans
New Resource Highlights Pharmacy’s Role in Health Information Exchange

Share Article